#PWID

Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.

The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.

U.S. health care systems are seeking better solutions to the critical problem of drug diversion.

This includes people who use drugs, those with psychiatric disorders and those with a history of alcohol use.

A pooled analysis of numerous clinical trials and real-world studies reached this conclusion.

New cases of all three viruses have declined in the city over the past decade.

Consistent use of medication-assisted treatment for opioid use disorder can apparently reduce this risk.

An analysis of newly diagnosed youths in California found they had limited access to opioid-related harm reduction services.

The drug can quickly reverse opioid-driven overdoses.

An analysis of hepatitis B testing among women of childbearing age found a declining national rate but increases in several states.

Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.

The mathematical model behind a new study is based on the patterns governing the spread of malaria via mosquitoes.

Governor Ron DeSantis signed the Infectious Disease Elimination Act, effective statewide July 1.

A new study finds strong support for the harm reduction strategy among those most likely to use them.

During a clinical trial for a new hep C treatment, David Whiters got cured.

Directly observed hep C treatment ups adherence in people who inject drugs.